Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Stock Forecast

Stock Price Forecast

According to 10 professional analysts, the 12-month price target for Celldex Therapeutics stock ranges from a low of $21 to a high of $67. The average analyst price target of $43.8 forecasts a 48.73% increase in the stock price over the next year.

Price Target: $43.80 (+48.73%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$21	$43.8	$43	$67
Change	-28.69%	+48.73%	+46.01%	+127.50%

Analyst Ratings

The average analyst rating for Celldex Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	4	4	4	4	4	4
Buy	2	2	3	3	4	4
Hold	3	3	2	2	1	1
Sell	0	0	0	0	1	1
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Etzer Darout Barclays	Barclays	Sell Maintains $25 → $21	Sell	Maintains	$25 → $21	-28.69%	Nov 11, 2025
Joseph Catanzaro Mizuho	Mizuho	Buy Initiates $48	Buy	Initiates	$48	+62.99%	Oct 21, 2025
Etzer Darout Barclays	Barclays	Sell Initiates $25	Sell	Initiates	$25	-15.11%	Oct 13, 2025
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $62	Strong Buy	Maintains	$62	+110.53%	Sep 17, 2025
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $44 → $38	Buy	Maintains	$44 → $38	+29.03%	Aug 20, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.66M

Decreased by -62.18%

from 7.02M

Revenue Next Year

3.18M

Increased by 19.70%

from 2.66M

EPS This Year

-3.73

from -2.45

EPS Next Year

-4.47

from -3.73

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	7.42M	4.65M	2.36M	6.88M	7.02M	2.66M	3.18M
Revenue Growth	107.61%	-37.30%	-49.32%	192.02%	1.99%	-62.18%	19.70%
EPS	-2.02	-1.64	-2.40	-2.92	-2.45	-3.73	-4.47
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	17	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	7.4M	12.6M
Avg	2.7M	3.2M
Low	1.4M	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	4.7%	374.6%
Avg	-62.2%	19.7%
Low	-80.5%	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-3.74	-4.21
Avg	-3.73	-4.47
Low	-3.64	-4.77

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.